Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas

ÇİÇİN İ., Ozatli T., Turkmen E., Ozturk T., Ozcelik M., ÇABUK D., ...Daha Fazla

BALKAN MEDICAL JOURNAL, cilt.33, sa.5, ss.517-524, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 5
  • Basım Tarihi: 2016
  • Doi Numarası: 10.5152/balkanmedj.2016.151268
  • Dergi Adı: BALKAN MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.517-524
  • Anahtar Kelimeler: Carcinosarcoma, ovary, uterine, predictive factors, prognostic factors, MIXED MULLERIAN TUMOR, SURGICAL CYTOREDUCTION, ADJUVANT-THERAPY, STAGE-I, SURVIVAL, CHEMOTHERAPY, VARIABLES, SURGERY
  • Gazi Üniversitesi Adresli: Evet

Özet

Background: Prognostic factors and the standard treatment approach for gynaecological carcinosarcomas have not yet been clearly defined. Although carcinosarcomas are more aggressive than pure epithelial tumours, they are treated similarly. Serous/clear cell and endometrioid components may be predictive factors for the efficacy of adjuvant chemotherapy (CT) or radiotherapy (RT) or RT in patients with uterine and ovarian carcinosarcomas. Heterologous carcinosarcomas may benefit more from adjuvant CT.